Hackensack University Medical Center Becomes First in New Jersey to Offer New Procedure to Diagnose Heart Disease in Small Blood Vessels

Published:
June 28, 2023

What You Need To Know

  • Interventional cardiologists at Hackensack University Medical Center are the first in the state to utilize a new method to assess the health of smaller arteries in the heart to pinpoint microvascular disease.
  • Doctors use the Coroventis CoroFlow Cardiovascular System during coronary angiography to evaluate key measures of heart function and diagnose or rule out cardiac small vessel disease in people with symptoms such as chest pain — especially those with no evidence of significant blockages in the major coronary arteries.
“The CoroFlow Cardiovascular System is a revolutionary diagnostic tool that’s only available at a handful of U.S. heart centers, including at Hackensack University Medical Center,” said Hackensack interventional cardiologist Ankitkumar Patel, MD. “It allows us to diagnose coronary microvascular dysfunction caused by invisible blockages in the heart’s smallest arteries." The physicians at Hackensack University Medical Center have done more than 50 cases with it since first using the Cardiovascular System in March.